As of 2025-05-29, the Fair Value of Mithra Pharmaceuticals SA (MITRA.BR) is -16.74 EUR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.22 EUR, the upside of Mithra Pharmaceuticals SA is -7,848.50%.
With the market price of 0.22 EUR and our fair value calculation, Mithra Pharmaceuticals SA (MITRA.BR) is not a good investment. Investing in MITRA.BR stocks now will result in a potential loss of 7,848.50%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -26.57 | -92.09 | -116.87 | -59.62 | -173.50 | -93.73 |
| YoY growth | -114.88% | -246.65% | -26.92% | 48.99% | -191.02% | -106.09% |
| Market Cap (mil) | 14.45 |
| P/E | |
| Forward P/E |
| EPS | -3.35 |
| Avg earnings growth rate | -106.09% |
| TTM earnings | -223.97 |